Colorectal Cancer Screening and Surveillance in Patients with Inflammatory Bowel Disease in 2021

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2022 Mar 23

PMID 35316962

Authors

Jose Maria Huguet

Luis Ferrer-Barcelo

Patricia Suarez

Eva Sanchez

Jose David Prieto

Victor Garcia

Javier Sempere

Affiliations

Soon will be listed here.

Abstract

The detection of dysplasia in patients with inflammatory bowel disease (IBD) continues to be important given the increased risk of colorectal cancer in this population. Therefore, in 2017, we performed a review and update of the recommendations for the management and follow-up of patients with IBD based on the clinical practice guidelines of various scientific societies. The present manuscript focuses on new aspects of the detection, follow-up, and management of dysplasia according to the latest studies and recommendations. While chromoendoscopy with targeted biopsy continues to be the technique of choice for the screening and detection of dysplasia in IBD, the associated difficulties mean that it is now being compared with other techniques (virtual chromoendoscopy), which yield similar results with less technical difficulties. Furthermore, the emergence of new endoscopy techniques that are still being researched but seem promising (, confocal laser endomicroscopy and full-spectrum endoscopy), together with the development of devices that improve endoscopic visualization (, Endocuff Vision), lead us to believe that these approaches can revolutionize the screening and follow-up of dysplasia in patients with IBD. Nevertheless, further studies are warranted to define the optimal follow-up strategy in this patient population.

Citing Articles

Inflammatory Bowel Disease and Colorectal Cancer.

Fanizza J, Bencardino S, Allocca M, Furfaro F, Zilli A, Parigi T Cancers (Basel). 2024; 16(17).

PMID: 39272800 PMC: 11394070. DOI: 10.3390/cancers16172943.

Nissle 1917 Protects against Sepsis-Induced Intestinal Damage by Regulating the SCFA/GPRs Signaling Pathway.

Wang Y, Deng H, Xiao L, Pan Y Microorganisms. 2024; 12(8).

PMID: 39203464 PMC: 11356217. DOI: 10.3390/microorganisms12081622.

The Preventive Effect of Low-Molecular Weight Oyster Peptides on Lipopolysaccharide-Induced Acute Colitis in Mice by Modulating Intestinal Microbiota Communities.

Wu Q, Lin H, Shen W, Cao W, Qin X, Gao J Foods. 2024; 13(15).

PMID: 39123582 PMC: 11311859. DOI: 10.3390/foods13152391.

Malignant Transformation of Long-Standing Ileal Crohn's Disease Likely Favors Signet Ring Cell Adenocarcinoma Histology.

Benesch M, Nelson E, OBrien S World J Oncol. 2023; 14(6):447-456.

PMID: 38022405 PMC: 10681788. DOI: 10.14740/wjon1605.

Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management.

Sato Y, Tsujinaka S, Miura T, Kitamura Y, Suzuki H, Shibata C Cancers (Basel). 2023; 15(16).

PMID: 37627182 PMC: 10452690. DOI: 10.3390/cancers15164154.

References

Fang W, Haridy J, Keung C, Van Langenberg D, Saunders B, Garg M . Endocuff Vision is safe to use for dysplasia surveillance in patients with ulcerative colitis: a feasibility study. Endosc Int Open. 2019; 7(9):E1044-E1048. PMC: 6713553. DOI: 10.1055/a-0886-6421. View

Nouda S, Ota K, Higuchi K . Retrograde colon capsule endoscopy with the self-propelling capsule endoscope: The first human trial (with videos). Dig Endosc. 2017; 30(1):117-118. DOI: 10.1111/den.12969. View

Ten Hove J, Mooiweer E, Dekker E, van der Meulen-de Jong A, Offerhaus G, Ponsioen C . Low Rate of Dysplasia Detection in Mucosa Surrounding Dysplastic Lesions in Patients Undergoing Surveillance for Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2016; 15(2):222-228.e2. DOI: 10.1016/j.cgh.2016.08.035. View

Tung B, Emond M, Haggitt R, Bronner M, Kimmey M, Kowdley K . Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med. 2001; 134(2):89-95. DOI: 10.7326/0003-4819-134-2-200101160-00008. View

Hosoe N, Kamiya K, Hayashi Y, Sujino T, Ogata H, Kanai T . Current status of colon capsule endoscopy. Dig Endosc. 2020; 33(4):529-537. DOI: 10.1111/den.13769. View

Hata K, Ishihara S, Ajioka Y, Mitsuyama K, Watanabe K, Hanai H . Long-Term Follow-Up of Targeted Biopsy Yield (LOFTY Study) in Ulcerative Colitis Surveillance Colonoscopy. J Clin Med. 2020; 9(7). PMC: 7408776. DOI: 10.3390/jcm9072286. View

Cairns S, Scholefield J, Steele R, Dunlop M, Thomas H, Evans G . Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010; 59(5):666-89. DOI: 10.1136/gut.2009.179804. View

Burke K, Nayor J, Campbell E, Ananthakrishnan A, Khalili H, Richter J . Interval Colorectal Cancer in Inflammatory Bowel Disease: The Role of Guideline Adherence. Dig Dis Sci. 2019; 65(1):111-118. PMC: 6946853. DOI: 10.1007/s10620-019-05754-9. View

Rubin D, Ananthakrishnan A, Siegel C, Sauer B, Long M . ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019; 114(3):384-413. DOI: 10.14309/ajg.0000000000000152. View

10.

Itzkowitz S, Present D . Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005; 11(3):314-21. DOI: 10.1097/01.mib.0000160811.76729.d5. View

11.

Pardi D, Loftus Jr E, Kremers W, Keach J, Lindor K . Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology. 2003; 124(4):889-93. DOI: 10.1053/gast.2003.50156. View

12.

De Palma G, Colavita I, Zambrano G, Giglio M, Maione F, Luglio G . Detection of colonic dysplasia in patients with ulcerative colitis using a targeted fluorescent peptide and confocal laser endomicroscopy: A pilot study. PLoS One. 2017; 12(6):e0180509. PMC: 5493408. DOI: 10.1371/journal.pone.0180509. View

13.

Goetz M, Malek N, Kiesslich R . Microscopic imaging in endoscopy: endomicroscopy and endocytoscopy. Nat Rev Gastroenterol Hepatol. 2013; 11(1):11-8. DOI: 10.1038/nrgastro.2013.134. View

14.

Huguet J, Suarez P, Ferrer-Barcelo L, Iranzo I, Sempere J . Screening for colorectal cancer in patients with inflammatory bowel disease. Should we already perform chromoendoscopy in all our patients?. World J Gastrointest Endosc. 2018; 10(11):322-325. PMC: 6247098. DOI: 10.4253/wjge.v10.i11.322. View

15.

Zhao L, Li J, Yu T, Chen G, Yuan Y, Chen Q . 5-Aminosalicylates reduce the risk of colorectal neoplasia in patients with ulcerative colitis: an updated meta-analysis. PLoS One. 2014; 9(4):e94208. PMC: 3978022. DOI: 10.1371/journal.pone.0094208. View

16.

van Doorn S, van der Vlugt M, Depla A, Wientjes C, Mallant-Hent R, Siersema P . Adenoma detection with Endocuff colonoscopy versus conventional colonoscopy: a multicentre randomised controlled trial. Gut. 2015; 66(3):438-445. DOI: 10.1136/gutjnl-2015-310097. View

17.

Bisschops R, Bessissow T, Joseph J, Baert F, Ferrante M, Ballet V . Chromoendoscopy versus narrow band imaging in UC: a prospective randomised controlled trial. Gut. 2017; 67(6):1087-1094. DOI: 10.1136/gutjnl-2016-313213. View

18.

Wang P, Liu P, Glissen Brown J, Berzin T, Zhou G, Lei S . Lower Adenoma Miss Rate of Computer-Aided Detection-Assisted Colonoscopy vs Routine White-Light Colonoscopy in a Prospective Tandem Study. Gastroenterology. 2020; 159(4):1252-1261.e5. DOI: 10.1053/j.gastro.2020.06.023. View

19.

Beaugerie L, Svrcek M, Seksik P, Bouvier A, Simon T, Allez M . Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology. 2013; 145(1):166-175.e8. DOI: 10.1053/j.gastro.2013.03.044. View

20.

Steward W, Brown K . Cancer chemoprevention: a rapidly evolving field. Br J Cancer. 2013; 109(1):1-7. PMC: 3708589. DOI: 10.1038/bjc.2013.280. View